Stay updated on ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include a comprehensive list of drugs used in the treatment of various types of lymphomas, while significant details regarding the study phases and inclusion/exclusion criteria have been removed.SummaryDifference9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has been updated to reflect a change in terminology from 'Lymphosarcoma' to 'B-cell Lymphoma' and has been revised from version 2.14.2 to 2.14.3.SummaryDifference0.2%
- Check45 days agoChange DetectedDifference0.1%
Stay in the know with updates to ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial page.